{
    "2018-01-23": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Biotech, M&A, Off to a Strong Start in 2018: More Deals to Follow?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "M&A",
                        "Strong Start"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Reading the Estimates for Novartis’s Alcon in 4Q17",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "Estimates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What’s Expected of Novartis’s Sandoz Segment in 4Q17?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sandoz",
                        "Expected"
                    ],
                    "sentiment_score": 0.55,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}